Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer mortality after iodine-131 therapy for hyperthyroidism.
Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J, Wiklund K, et al. Hall P, et al. Among authors: berg g. Int J Cancer. 1992 Apr 1;50(6):886-90. doi: 10.1002/ijc.2910500611. Int J Cancer. 1992. PMID: 1555888
Leukaemia incidence after iodine-131 exposure.
Hall P, Boice JD Jr, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Mattsson A, Tennvall J, et al. Hall P, et al. Among authors: berg g. Lancet. 1992 Jul 4;340(8810):1-4. doi: 10.1016/0140-6736(92)92421-b. Lancet. 1992. PMID: 1351599
[Low risk of cancer after treatment of hyperthyroidism with iodine-131].
Holm LE, Hall P, Lundell G, Berg G, Bjelkengren G, Ericsson UB, Tennvall J, Hallquist A, Lidberg M, Wiklund K. Holm LE, et al. Among authors: berg g. Lakartidningen. 1992 Sep 16;89(38):3043-6. Lakartidningen. 1992. PMID: 1369747 Swedish. No abstract available.
Cancer risk after iodine-131 therapy for hyperthyroidism.
Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG, et al. Holm LE, et al. Among authors: berg g. J Natl Cancer Inst. 1991 Aug 7;83(15):1072-7. doi: 10.1093/jnci/83.15.1072. J Natl Cancer Inst. 1991. PMID: 1875414
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
Träisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Ponjavic V, Taube A, Törring O, Wallin G, Asman P, Lundell G; Thyroid Study Group of TT 96. Träisk F, et al. Among authors: berg g. J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. doi: 10.1210/jc.2009-0747. Epub 2009 Sep 1. J Clin Endocrinol Metab. 2009. PMID: 19723755 Clinical Trial.
Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.
Abraham-Nordling M, Wallin G, Träisk F, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Asman P, Lundell G, Törring O; Thyroid Study Group of TT 96. Abraham-Nordling M, et al. Among authors: berg g. Eur J Endocrinol. 2010 Oct;163(4):651-7. doi: 10.1530/EJE-10-0475. Epub 2010 Jul 21. Eur J Endocrinol. 2010. PMID: 20660002 Clinical Trial.
Incidence of hyperthyroidism in Sweden.
Abraham-Nordling M, Byström K, Törring O, Lantz M, Berg G, Calissendorff J, Nyström HF, Jansson S, Jörneskog G, Karlsson FA, Nyström E, Ohrling H, Orn T, Hallengren B, Wallin G. Abraham-Nordling M, et al. Among authors: berg g. Eur J Endocrinol. 2011 Dec;165(6):899-905. doi: 10.1530/EJE-11-0548. Epub 2011 Sep 9. Eur J Endocrinol. 2011. PMID: 21908653
1,579 results